AI assistant
Sending…
Ocugen, Inc. — Director's Dealing 2021
Dec 18, 2021
32915_dirs_2021-12-17_a62c688c-a965-48fb-bc98-cef67abe7632.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Ocugen, Inc. (OCGN)
CIK: 0001372299
Period of Report: 2021-11-16
Reporting Person: Zhang Junge (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-16 | Common Stock | X | 143820 | $2.77 | Acquired | 875251 | Indirect |
| 2021-11-16 | Common Stock | X | 1653 | $7.56 | Acquired | 876904 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-16 | Warrants (Right to Buy) | $2.77 | X | 143820 | Disposed | 2026-11-18 | Common Stock (143820) | Indirect |
| 2021-11-16 | Warrants (Right to Buy) | $7.56 | X | 1653 | Disposed | 2027-06-17 | Common Stock (1653) | Indirect |
Footnotes
F1: This Form 4 is being filed late due to an administrative error.
More from Ocugen, Inc.
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 5
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4